Monthly Archives: April 2017

Thor Halvorssen Is President and CEO of the Human Rights Foundation

Thor Halvorssen is a human rights promoter and film maker. Depicted by the New York Times as “a champion of the powerless and underdog,” he started upholding for human rights as a pre-adult in 1989 in London by organizing how to oppose the South African politically-sanctioned racial segregation. Thor Halvorssen’s experience is Norwegian and Venezuelan. He got to be distinctly involved full-time in the advancement of due process and individual rights after his dad became a political detainee in Venezuela. He established the New York-based Human Rights Foundation after his mom was shot amid a political challenge there in 2004. HRF is dedicated to freeing political detainees while ensuring promoting of democracy and political protest in Latin America. Since its establishing, Human Rights Foundation has secured the freedom of seven conscience detainees, forwarded evidence to Truth Commissions, provided amicus briefs in key global human rights cases, and ensured publication of two books on human rights and state responsibility. Mr. Halvorssen is originator and CEO of the Oslo Freedom Forum, a yearly worldwide social group portrayed by The Economist as a “breathtaking human-rights celebration on the way to become a human-rights team similar with the Davos economic forum.” Halvorssen is likewise the Patron of the Prague-based Children’s Peace Movement; On Own Feet and read full article.

Halvorssen is a Venezuela’s nationality and born to Hilda Mendoza, a relative and a descendant, separately, of Venezuela’s first president Cristóbal Mendoza. His dad is Thor Halvorssen Hellum, who filled in as a Venezuelan Ambassador for anti-Narcotic Affairs in the organization of Carlos Andrés Pérez and as unique abroad agent of a Venezuelan Senate Commission. His family was prosperous and on his dad’s side he is the grandson of Øystein Halvorssen, the Norwegian ruler’s delegate who “established a family line as the Venezuelan agent for companies including Dunlop, Alfa Laval and Ericsson. His cousin is Leopoldo Lopez. In 1999, Halvorssen was selected as CEO and first executive director of FIRE – (Foundation for Individual Rights in Education), a U.S. common freedoms association. As head of FIRE,Halvorssen shaped coalitions that united the moderate and libertarian promotion associations, for example, the Heritage Foundation, Feminists for Free Expression, the Eagle Forum, with more conventional free discourse protectors, for example, the ACLU. Halvorssen has a reputation of advocating for people both on the left and on the right of the political spectrum and Thor’s lacrosse camp.

Karl Heideck, A Leading Litigation Attorney In Philadelphia About Litigation

Karl Heideck litigation attorney in Philadelphia
Karl Heideck litigation attorney in Philadelphia

Litigation involves representing plaintiffs and defendants in civil law cases. Litigation involves discovery, investigation, trial, pre-trial, appeal and settlement. Ligation means large firm or sole practitioner, litigators. Company based litigators have most duties depending with regards to their seniority. However, all litigators first commence their careers by writing memos and conducting research.

New litigators gain court exposure by first arguing in their gallery sitting positions. These lawyers first the chance to represent clients in Small Claims Court proceedings. Besides, attorneys also keep in contact with opposing and consumer counsel. Sole or independent proprietor attorneys also have combined research, real trial, and office experience. The litigators’ salary depends on the area of specialty.

About Karl Heideck
Karl Heideck is a prominent litigator in Philadelphia. He has considerable experience in risk management, litigation as well as compliance and has served the Greater Philadelphia area for many years now. He currently acts as the Eisenhofer and Grant Hire Counsel contract attorney. Before this, he used to work for Conrad O’Brien and Pepper Hamilton LLP.

He learned at the James E. Beasley Temple University Law School. Some of his skills include litigation, product liability, commercial litigation, courts, employment law teaching, intellectual property, appeals, arbitration, corporate law, legal research, mediation, civil litigation, legal writing, trials, and Westlaw.

Karl Heideck has worked for Wilmington Delaware Eisenhofer and Grant for two years now as a contract attorney. He has been responsible for reviewing major complex materials involving securities fraud and banking litigation. Karl Heideck also specializes in matters relating to liquidity, acquisitions, and management.

At Pepper Hamilton LLP, he worked for one year and was responsible for detailing quality control, top level, and detail oriented specialist litigations. He worked four years with Conrad O’Brien where he served many complex disputes and corporate commercial clients. Customers can contact Karl Heideck on (215) 292-6910.

EOS Lip Balm Reaches New Heights as They Surpass Competitors

What do you think of when it comes to lip balms? Chapstick and Blistex are a couple of brands that come to mind. They have been around for decades and have been the trusted brand for many. The lip balm market has been overlooked and that has made that area stale. But EOS lip balm has taken a new approach, creating a whole new everything that has captured the consumer’s eyes.

For years lip balms consisted of the same boring cylinder tube that offered very little to the consumer. Yes, it moisturized the lips, and offered two flavors, cherry and mint, if you wanted to spice it up. But all that seemed clinical, no fun at all. EOS lip balm changed that offering exciting new flavor that taste just as great as it smells. The outlook on lip balms have changed, going from tube like blandness to a spherical shape with scents and tastes that gives you that spice that you lack.

EOS didn’t burst out on the scene like a hurricane. They eased their way in concentrating all efforts on development of the products and getting them out there. With them being a small startup company, their resources had to go to the importance of distribution and production first and foremost. They made their way through the shelves of Target and Walmart as well as online on Amazon. With this tactic, they slipped right in, taking the number 2 spot just behind Burt’s Bees lip balm. That knocked Chapstick, Blistex, and other known brands down as this new lip balm company quickly gained ground.

Right now, their company is worth about $250 million. Kline Research estimates that they will reach over $2 billion by the year 2020. And that leaves the puzzling question as to how did they gain so much popularity so quickly. They were smart, letting the product sell itself once they gained entry into the retail world. For more info, visit

Product Link:

Talk Fusion CEO Bob Reina Writes Column for MarTech Advisor

What does one of the hardest working businessmen in the communications industry do in order to take some time off? Well, they return to MarTech Advisor in order to pen a guest column. Bob Reina is the CEO and Founder of Talk Fusion. Talk Fusion was established back in 2007 and it has become the industry leader in video marketing and communication solutions between clients and customers. Reina decided to come back to MarTech Advisor, one of the biggest publications for entrepreneurs, in order to write a little bit about his experience.


When coming back to MarTech Advisor Reina wanted to make sure that he left an impression from a place in his heart that he had experience: video marketing. Reina was one of the few individuals to properly forecast just how big video marketing would be in the future. This lead Reina to pen the article, “Video Advertising Trends of 2017′. Reina firmly believes that you need to be at the forefront of a movement’s knowledge in order to navigate through the industry. Reina’s work is now hosted by MarTech Advisor which is read by prominent Chief Marketing Officers all over the world.


Reina was ecstatic when brought back on board to write for MarTech Advisor. Reina stated, ” I’m glad to share my vision and insight with MarTech Advisor readers. So they can grow with this medium and learn why now is the time to make video the center of their marketing strategy.” Reina’s words are far from empty platitudes as his work has now been read and shared by countless people since being hosted on MarTech Advisor.


To say that Reina dabbles as a writer would be an understatement. Reina has put his work on the internet via text form for The Huffington Post as well as MarTech, showing that his experience has reach to a broad and varied audience. Reina first wrote for MarTech Advisor back in May of 2016 and his work was so well received that he was brought back on board to share more of his information. Right now more than 1.1 million readers will be setting their eyes on Reina’s new work.


An Advertising Guru In Brazil

José Borghi, founder of a renowned Mullen Lowe agency. Due to his expertise, in-depth analysis skills and a keen eye on the client’s request, he considered as the most influential advertisers in whole Brazil. The presence of Borghi among the most creative advertising personality in whole Brazil was because of many reasons, including the competence of launching diverse campaigns.

He is also the inventor of repercussion campaigns such as Mammals of Parmalat. In MoP, kids wear outfits of stuffed animals and sang memorable jingles. In his early hood, in was not sure which career to shoot. While still in high school, he went to the Castro Neves Theater to see the performance of his sister. From there, Borghi already knew what career should he aim for, but he wouldn’t predict that in he will win Cannes Lion award one day.

José Henrique Borghi, born at Presidente Prudente earned his professional education from PUC-Campinas in Propaganda and Advertising. His first professional was in the year 1989 at an advertisement agency Standart Ogilvy and by working in many companies, he becomes Entrepreneur by inaugurating his firm Mullen Lowe. This agency has gained and grown even more evidence in the local and global market. By having a merger between the Mullen group and Lowe & Partners, the agency has become Mullen Lowe. An advertiser who is also a Marathon runner trusted in his ability, and he turned out to be the reliable and one of the trusted names in the advertising industry.

The awards that he earned in his extensive career as one of the most renowned and trusted advertising tycoons are not limited to very few. He honored with seven London Festival statuettes awards; fourteen for Cannes Festival lions, ten awards from The One Show, 10 for The New York Festival and his agency also accredited as the Brazilian Advertising Festival.

Helane Morrison: Regulatory and Compliance Law Pioneer

Helane Morrison is the Chief Compliance Officer of Hall Capital Partners in San Francisco. She began her career as a regulator with the SEC, eventually rising to the position of Regional Director for the Pacific Northwest. Based in San Francisco, Morrison took on a number of high-profile cases in the wake of the financial crisis of 2007-8. She disciplined executives at several major corporations and was involved in the prosecution of an insurance company that was responsible for defrauding tens of thousands of members of the armed services.


Prior to joining the SEC, she clerked for Supreme Court Justice Blackmun. A graduate of UC Berkeley Law School, she practiced law at one of San Francisco’s top law firms, eventually becoming a partner. Her career as a litigator and regulator makes her uniquely qualified in her career as a compliance officer. Hall Capital has more than $24 billion under management and is one of the most prestigious female-led equity firms in the United States. Morrison is part of an elite leadership team that includes Co-CIO Kathryn Hall and company President Sarah Stein.


Throughout her career, Morrison has never been known to back down from a challenge. Despite the financial rewards of private practice and the prestige of her Supreme Court clerkship, Morrison did not simply rest on her laurels. Her commitment to justice and fairness led her to carve out a career in financial regulation. In addition to making the financial marketplace safer for individuals and families everywhere, she has set an example for American lawyers.



Clay Siegall builds biotech empire from scratch

Clay Siegall first became aware of the brutality of chemotherapy while still in college. He decided that he would like to dedicate himself to finding new ways to treat and maybe someday cure the disease, which kills more people than anything else in the United States.


After working for a decade in various capacities with the National Cancer Institute as well as Bristol Meyers Squibb, Siegall founded Seattle Genetics, a biotech firm dedicated to the development of antibody drug conjugates. Antibody drug conjugates are a type of cancer treatment that has the same primary effects of chemotherapy but without the horrible side effects.

When he founded his company, Siegall had just a skeleton staff and a few million dollars in venture capital. But over the next three years, he built the company into a respectable research firm, with multiple patents to its credit. In 2001, Siegall led Seattle Genetics’ IPO. It raised over $1 billion. This was one of the most successful IPOs in biotech history and quickly propelled Seattle Genetics to the upper echelons of cutting-edge cancer treatment innovators.


Over the next decade, the company developed many of its own drugs. In 2011, it received FDA approval for its first patient-ready drug, ADCetris. ADCetris is an antibody drug conjugate approved for use in certain cases of refractory non-Hodgkin lymphoma. This drug has saved hundreds of lives and incalculable suffering by sparing its users from the horrors of chemotherapy.

Seattle Genetics currently has twelve drugs in the development pipeline and many more that are leased out to other firms for production and further development. It has developed a large number of proprietary processes for the synthesis of antibody drug conjugates as well as many of its own biochemical processes. Today, Seattle Genetics ranks among the most prominent players in the alternative drug cancer research space.

It expects at least five more drugs to receive FDA approval in the next few years. This will solidify its competitive position and free up more resources for its continued development of innovative cancer treatments. It is hoped by Dr. Clay  Siegall that someday soon, one of those drugs may even include a cure.